News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,154 Results
Type
Article (42702)
Company Profile (439)
Press Release (678012)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (208900)
Career Advice (2025)
Deals (36047)
Drug Delivery (104)
Drug Development (83715)
Employer Resources (173)
FDA (16514)
Job Trends (15136)
News (353218)
Policy (33157)
Tag
Academia (2645)
Accelerated approval (12)
Adcomms (26)
Allergies (98)
Alliances (51113)
ALS (115)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (168)
Approvals (16493)
Artificial intelligence (331)
Autoimmune disease (33)
Automation (19)
Bankruptcy (373)
Best Places to Work (11846)
BIOSECURE Act (19)
Biosimilars (124)
Biotechnology (331)
Bladder cancer (98)
Brain cancer (36)
Breast cancer (375)
Cancer (2965)
Cardiovascular disease (227)
Career advice (1695)
Career pathing (30)
CAR-T (194)
CDC (32)
Cell therapy (527)
Cervical cancer (22)
Clinical research (68714)
Collaboration (1070)
Company closure (3)
Compensation (703)
Complete response letters (28)
COVID-19 (2685)
CRISPR (65)
C-suite (344)
Cystic fibrosis (119)
Data (3064)
Decentralized trials (2)
Denatured (31)
Depression (71)
Diabetes (351)
Diagnostics (6486)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (147)
Drug pricing (130)
Drug shortages (29)
Duchenne muscular dystrophy (137)
Earnings (88722)
Editorial (44)
Employer branding (21)
Employer resources (149)
Events (117391)
Executive appointments (874)
FDA (18199)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (977)
Gene editing (143)
Generative AI (23)
Gene therapy (407)
GLP-1 (826)
Government (4594)
Grass and pollen (4)
Guidances (182)
Healthcare (19175)
HIV (42)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (164)
Immuno-oncology (9)
Indications (40)
Infectious disease (2861)
Inflammatory bowel disease (157)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (122)
Interviews (312)
IPO (16875)
IRA (47)
Job creations (3708)
Job search strategy (1436)
Kidney cancer (13)
Labor market (53)
Layoffs (526)
Leadership (20)
Legal (8006)
Liver cancer (80)
Longevity (11)
Lung cancer (416)
Lymphoma (212)
Machine learning (11)
Management (58)
Manufacturing (401)
MASH (95)
Medical device (13618)
Medtech (13623)
Mergers & acquisitions (19894)
Metabolic disorders (888)
Multiple sclerosis (99)
NASH (19)
Neurodegenerative disease (132)
Neuropsychiatric disorders (39)
Neuroscience (2222)
NextGen: Class of 2025 (6760)
Non-profit (4562)
Now hiring (47)
Obesity (452)
Opinion (237)
Ovarian cancer (103)
Pain (113)
Pancreatic cancer (122)
Parkinson's disease (193)
Partnered (22)
Patents (306)
Patient recruitment (171)
Peanut (51)
People (59107)
Pharmaceutical (86)
Pharmacy benefit managers (22)
Phase I (21594)
Phase II (30326)
Phase III (22397)
Pipeline (1670)
Policy (212)
Postmarket research (2601)
Preclinical (9279)
Press Release (67)
Prostate cancer (146)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (492)
Real estate (6025)
Recruiting (67)
Regulatory (23125)
Reports (50)
Research institute (2422)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (169)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3776)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (57)
The Weekly (58)
Vaccines (802)
Venture capital (56)
Weight loss (278)
Women's health (49)
Worklife (17)
Date
Today (79)
Last 7 days (361)
Last 30 days (1908)
Last 365 days (32054)
2025 (17352)
2024 (36307)
2023 (41017)
2022 (52279)
2021 (56770)
2020 (54923)
2019 (47421)
2018 (35701)
2017 (33031)
2016 (32352)
2015 (38402)
2014 (32188)
2013 (27111)
2012 (29225)
2011 (29865)
2010 (27993)
Location
Africa (738)
Alabama (67)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (39666)
Australia (6581)
California (7618)
Canada (2381)
China (697)
Colorado (329)
Connecticut (334)
Delaware (195)
Europe (86759)
Florida (1128)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (660)
India (27)
Indiana (365)
Iowa (19)
Japan (232)
Kansas (112)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1049)
Massachusetts (5756)
Michigan (248)
Minnesota (460)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (70)
New Jersey (2123)
New Mexico (30)
New York (2122)
North Carolina (1153)
North Dakota (9)
Northern California (3324)
Ohio (240)
Oklahoma (16)
Oregon (38)
Pennsylvania (1634)
Puerto Rico (17)
Rhode Island (37)
South America (1112)
South Carolina (34)
South Dakota (1)
Southern California (2843)
Tennessee (126)
Texas (1149)
United States (28334)
Utah (223)
Virginia (193)
Washington D.C. (74)
Washington State (660)
West Virginia (4)
Wisconsin (70)
721,154 Results for "allos therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
June 2, 2025
·
4 min read
Press Releases
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
June 2, 2025
·
9 min read
Press Releases
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
May 23, 2025
·
7 min read
Press Releases
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
March 4, 2025
·
7 min read
Press Releases
Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
8 min read
Press Releases
MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
February 24, 2025
·
6 min read
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Press Releases
MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
January 23, 2025
·
4 min read
Press Releases
Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases
January 28, 2025
·
7 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 72,116
Next
